Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis
- PMID: 24366731
- PMCID: PMC3957869
- DOI: 10.1128/AAC.01775-13
Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis
Abstract
The mechanistic basis for the resistance of Mycobacterium tuberculosis to para-aminosalicylic acid (PAS), an important agent in the treatment of multidrug-resistant tuberculosis, has yet to be fully defined. As a substrate analog of the folate precursor para-aminobenzoic acid, PAS is ultimately bioactivated to hydroxy dihydrofolate, which inhibits dihydrofolate reductase and disrupts the operation of folate-dependent metabolic pathways. As a result, the mutation of dihydrofolate synthase, an enzyme needed for the bioactivation of PAS, causes PAS resistance in M. tuberculosis strain H37Rv. Here, we demonstrate that various missense mutations within the coding sequence of the dihydropteroate (H2Pte) binding pocket of dihydrofolate synthase (FolC) confer PAS resistance in laboratory isolates of M. tuberculosis and Mycobacterium bovis. From a panel of 85 multidrug-resistant M. tuberculosis clinical isolates, 5 were found to harbor mutations in the folC gene within the H2Pte binding pocket, resulting in PAS resistance. While these alterations in the H2Pte binding pocket resulted in reduced dihydrofolate synthase activity, they also abolished the bioactivation of hydroxy dihydropteroate to hydroxy dihydrofolate. Consistent with this model for abolished bioactivation, the introduction of a wild-type copy of folC fully restored PAS susceptibility in folC mutant strains. Confirmation of this novel PAS resistance mechanism will be beneficial for the development of molecular method-based diagnostics for M. tuberculosis clinical isolates and for further defining the mode of action of this important tuberculosis drug.
Figures
Similar articles
-
Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains.Emerg Microbes Infect. 2019;8(1):248-261. doi: 10.1080/22221751.2019.1568179. Emerg Microbes Infect. 2019. PMID: 30866779 Free PMC article.
-
Phylogenetic and Structural Significance of Dihydrofolate Synthase (folC) Mutations in Drug-Resistant Mycobacterium tuberculosis.Microb Drug Resist. 2016 Oct;22(7):545-551. doi: 10.1089/mdr.2015.0193. Epub 2016 Apr 15. Microb Drug Resist. 2016. PMID: 27082669
-
Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations.Ann Clin Microbiol Antimicrob. 2022 Nov 5;21(1):48. doi: 10.1186/s12941-022-00537-z. Ann Clin Microbiol Antimicrob. 2022. PMID: 36335391 Free PMC article.
-
Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.Antimicrob Agents Chemother. 2015 Sep;59(9):5097-106. doi: 10.1128/AAC.00647-15. Epub 2015 Jun 1. Antimicrob Agents Chemother. 2015. PMID: 26033719 Free PMC article. Review.
-
The aminosalicylate - folate connection.Drug Metab Rev. 2024 Feb;56(1):80-96. doi: 10.1080/03602532.2024.2303507. Epub 2024 Jan 17. Drug Metab Rev. 2024. PMID: 38230664 Review.
Cited by
-
The T120P or M172V mutation on rv2172c confers high level para-aminosalicylic acid resistance in Mycobacterium tuberculosis.Emerg Microbes Infect. 2024 Dec;13(1):2374030. doi: 10.1080/22221751.2024.2374030. Epub 2024 Jul 24. Emerg Microbes Infect. 2024. PMID: 39023395 Free PMC article.
-
Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains.Emerg Microbes Infect. 2019;8(1):248-261. doi: 10.1080/22221751.2019.1568179. Emerg Microbes Infect. 2019. PMID: 30866779 Free PMC article.
-
Cure of tuberculosis using nanotechnology: An overview.J Microbiol. 2018 May;56(5):287-299. doi: 10.1007/s12275-018-7414-y. Epub 2018 May 2. J Microbiol. 2018. PMID: 29721825 Review.
-
Deletion of sigB Causes Increased Sensitivity to para-Aminosalicylic Acid and Sulfamethoxazole in Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2017 Sep 22;61(10):e00551-17. doi: 10.1128/AAC.00551-17. Print 2017 Oct. Antimicrob Agents Chemother. 2017. PMID: 28717039 Free PMC article.
-
Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.J Antimicrob Chemother. 2017 Jul 1;72(7):1848-1857. doi: 10.1093/jac/dkx051. J Antimicrob Chemother. 2017. PMID: 28333284 Free PMC article. Review.
References
-
- Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575–1580. 10.1016/S0140-6736(06)69573-1 - DOI - PubMed
-
- World Health Organization 2012. Global tuberculosis report 2012 World Health Organization, Geneva, Switzerland: http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
